Skip to content
2000
Volume 21, Issue 10
  • ISSN: 1573-4013
  • E-ISSN: 2212-3881

Abstract

Background

Non-alcoholic fatty liver disease (NAFLD) is a prevalent liver condition associated with obesity, type 2 diabetes, and cardiovascular diseases. The rising global burden of NAFLD underscores the need for effective management strategies.

Methods

This review examines the impact of dietary modifications and physical exercise on insulin sensitivity and overall metabolic health in NAFLD patients. The review synthesizes current evidence on the effectiveness of physical activity and diet in improving liver function and reducing hepatic fat accumulation.

Results

Increased physical activity, including both aerobic and resistance exercises, has been shown to significantly reduce hepatic fat and improve insulin sensitivity in individuals with NAFLD. Additionally, complementary dietary interventions, such as the Mediterranean-style diet, enhance these effects. The review further discusses the role of inflammation and oxidative stress in the progression of NAFLD and the importance of personalized lifestyle interventions.

Conclusion

Effective management of NAFLD requires a multidisciplinary approach that incorporates lifestyle modifications, behavioral support, and emerging technologies for non-invasive diagnosis and disease monitoring. Future research should focus on personalized therapeutic strategies and the long-term sustainability of interventions to mitigate the global health impact of NAFLD.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnf/10.2174/0115734013384230250710024703
2025-07-21
2026-02-24

  • From This Site

    /content/journals/cnf/10.2174/0115734013384230250710024703
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. DiehlA.M. DayC. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis.N Engl J Med2017377212063207210.1056/NEJMra150351929166236
     [Google Scholar]
  2. YounossiZ.M. GolabiP. PaikJ.M. HenryA. Van DongenC. HenryL. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review.Hepatology20237741335134710.1097/HEP.000000000000000436626630
     [Google Scholar]
  3. BabuA.F. CsaderS. LokJ. Gómez-GallegoC. HanhinevaK. El-NezamiH. SchwabU. Positive effects of exercise intervention without weight loss and dietary changes in NAFLD-related clinical parameters: A systematic review and meta-analysis.Nutrients2021139313510.3390/nu1309313534579012
     [Google Scholar]
  4. McDonoughD.J. MathewM. PopeZ.C. SchreinerP.J. JacobsD.R. VanWagnerL.B. CarrJ.J. TerryJ.G. GabrielK.P. ReisJ.P. PereiraM.A. Aerobic and muscle-strengthening physical activity, television viewing, and nonalcoholic fatty liver disease: The CARDIA study.J Clin Med20231217560310.3390/jcm1217560337685671
     [Google Scholar]
  5. HaxhiJ. VitaleM. MattiaL. GiulianiC. SacchettiM. OrlandoG. IacobiniC. MeniniS. ZanusoS. NicolucciA. BalducciS. PuglieseG. Effect of sustained decreases in sedentary time and increases in physical activity on liver enzymes and indices in type 2 diabetes.Front Endocrinol (Lausanne)202415139385910.3389/fendo.2024.139385938854689
     [Google Scholar]
  6. Guzmán-CarrascoA. KapravelouG. López-JuradoM. BermúdezF. Andrés-LeónE. Terrón-CameroL.C. PradosJ. MelguizoC. PorresJ.M. MartínezR. A novel plant-based nutraceutical combined with exercise can revert oxidative status in plasma and liver in a diet-induced-obesity animal model.Antioxidants202413327410.3390/antiox1303027438539808
     [Google Scholar]
  7. MahmoudiS.K. TarzemaniS. AghajanzadehT. KasraviM. HatamiB. ZaliM.R. BaghaeiK. Exploring the role of genetic variations in NAFLD: Implications for disease pathogenesis and precision medicine approaches.Eur J Med Res202429119010.1186/s40001‑024‑01708‑838504356
     [Google Scholar]
  8. FigueroaG. Low Health literacy, lack of knowledge, and self-control hinder healthy lifestyles in diverse patients with steatotic liver disease.Dig Dis Sci20236923849810.1007/s10620‑023‑08212‑938112835
     [Google Scholar]
  9. TilgH. ByrneC.D. TargherG. NASH drug treatment development: Challenges and lessons.Lancet Gastroenterol Hepatol202381094395410.1016/S2468‑1253(23)00159‑037597527
     [Google Scholar]
  10. Zelber-SagiS. MooreJ.B. Practical lifestyle management of nonalcoholic fatty liver disease for busy clinicians.Diabetes Spectr2024371394710.2337/dsi23‑000938385102
     [Google Scholar]
  11. TreftsE. WilliamsA.S. WassermanD.H. Exercise and the regulation of hepatic metabolism.Prog Mol Biol Transl Sci201520322510.1016/bs.pmbts.2015.07.010
     [Google Scholar]
  12. SchneiderC.V. ZandvakiliI. ThaissC.A. SchneiderK.M. Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort.JHEP Reports20213310026310.1016/j.jhepr.2021.10026333898961
     [Google Scholar]
  13. van der WindtD.J. SudV. ZhangH. TsungA. HuangH. The effects of physical exercise on fatty liver disease.Gene Expr20181828910110.3727/105221617X1512484426640829212576
     [Google Scholar]
  14. GaydaM. RibeiroP.A.B. JuneauM. NigamA. Comparison of different forms of exercise training in patients with cardiac disease: Where does high-intensity interval training fit?Can J Cardiol201632448549410.1016/j.cjca.2016.01.01726927863
     [Google Scholar]
  15. HallsworthK. TrenellM. Physical Activity in NAFLD: What and How Much?Non-Alcoholic Fatty Liver DiseaseChamSpringer International Publishing202028930710.1007/978‑3‑319‑95828‑6_16
     [Google Scholar]
  16. El KhouryD. PauleyR.J. BersethC.L. Dietary approaches to managing nonalcoholic fatty liver disease.Nurse Pract2021462192610.1097/01.NPR.0000731560.23509.ff33399334
     [Google Scholar]
  17. Parra-VargasM. Rodriguez-EchevarriaR. Jimenez-ChillaronJ.C. Nutritional approaches for the management of nonalcoholic fatty liver disease: An evidence-based review.Nutrients20201212386010.3390/nu1212386033348700
     [Google Scholar]
  18. SunZ. WeiY. XuY. JiaoJ. DuanX. The use of traditional Chinese medicine in the treatment of non-alcoholic fatty liver disease: A review.Pharmacol Res Modern Chinese Med20241210047510.1016/j.prmcm.2024.100475
     [Google Scholar]
  19. KammounH.L. ChabanonH. HainaultI. LuquetS. MagnanC. KoikeT. FerréP. FoufelleF. GRP78 expression inhibits insulin and ER stress–induced SREBP-1c activation and reduces hepatic steatosis in mice.J Clin Invest200911951201121510.1172/JCI3700719363290
     [Google Scholar]
  20. MarchesiniG. BriziM. BianchiG. TomassettiS. BugianesiE. LenziM. McCulloughA.J. NataleS. ForlaniG. MelchiondaN. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome.Diabetes20015081844185010.2337/diabetes.50.8.184411473047
     [Google Scholar]
  21. SanyalA.J. Campbell-SargentC. MirshahiF. RizzoW.B. ContosM.J. SterlingR.K. LuketicV.A. ShiffmanM.L. CloreJ.N. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities.Gastroenterology200112051183119210.1053/gast.2001.2325611266382
     [Google Scholar]
  22. PasarínM. AbraldesJ.G. Rodríguez-VilarruplaA. La MuraV. García-PagánJ.C. BoschJ. Insulin resistance and liver microcirculation in a rat model of early NAFLD.J Hepatol20115551095110210.1016/j.jhep.2011.01.05321356259
     [Google Scholar]
  23. RoumansK.H.M. LindeboomL. VeeraiahP. RemieC.M.E. PhielixE. HavekesB. BrulsY.M.H. BrouwersM.C.G.J. StåhlmanM. AlssemaM. PetersH.P.F. de MutsertR. StaelsB. TaskinenM.R. BorénJ. SchrauwenP. Schrauwen-HinderlingV.B. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.Nat Commun2020111189110.1038/s41467‑020‑15684‑032312974
     [Google Scholar]
  24. PaulB. LewinskaM. AndersenJ.B. Lipid alterations in chronic liver disease and liver cancer.JHEP Reports20224610047910.1016/j.jhepr.2022.10047935469167
     [Google Scholar]
  25. TalamantesS. LisjakM. GilglioniE.H. Llamoza-TorresC.J. Ramos-MolinaB. GurzovE.N. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma.JHEP Reports20235910081110.1016/j.jhepr.2023.10081137575883
     [Google Scholar]
  26. BroadfieldL.A. DuarteJ.A.G. SchmiederR. BroekaertD. VeysK. PlanqueM. VriensK. KarasawaY. NapolitanoF. FujitaS. FujiiM. EtoM. HolvoetB. VangoitsenhovenR. Fernandez-GarciaJ. Van ElsenJ. DehairsJ. ZengJ. DooleyJ. RubioR.A. van PeltJ. GrünewaldT.G.P. ListonA. MathieuC. DerooseC.M. SwinnenJ.V. LambrechtsD. di BernardoD. KurodaS. De BockK. FendtS.M. Fat induces glucose metabolism in nontransformed liver cells and promotes liver tumorigenesis.Cancer Res20218181988200110.1158/0008‑5472.CAN‑20‑195433687947
     [Google Scholar]
  27. LewinskaM. Santos-LasoA. ArretxeE. AlonsoC. ZhuravlevaE. Jimenez-AgüeroR. EizaguirreE. ParejaM.J. Romero-GómezM. ArreseM. SuppliM.P. KnopF.K. OversoeS.K. VilladsenG.E. DecaensT. CarrilhoF.J. de OliveiraC.P.M.S. SangroB. MaciasR.I.R. BanalesJ.M. AndersenJ.B. The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.EBioMedicine20217310366110.1016/j.ebiom.2021.10366134740106
     [Google Scholar]
  28. LuY. LiN. GaoL. XuY.J. HuangC. YuK. LingQ. ChengQ. ChenS. ZhuM. FangJ. ChenM. OngC.N. Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma.Cancer Res201676102912292010.1158/0008‑5472.CAN‑15‑319926976432
     [Google Scholar]
  29. MuirK. HazimA. HeY. PeyressatreM. KimD.Y. SongX. BerettaL. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.Cancer Res201373154722473110.1158/0008‑5472.CAN‑12‑379723749645
     [Google Scholar]
  30. Cigrovski BerkovicM. Bilic-CurcicI. MrzljakA. CigrovskiV. NAFLD and physical exercise: Ready, steady, Go!Front Nutr2021873485910.3389/fnut.2021.73485934676233
     [Google Scholar]
  31. HashidaR. KawaguchiT. BekkiM. OmotoM. MatsuseH. NagoT. TakanoY. UenoT. KogaH. GeorgeJ. ShibaN. TorimuraT. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review.J Hepatol201766114215210.1016/j.jhep.2016.08.02327639843
     [Google Scholar]
  32. FarzanegiP. DanaA. EbrahimpoorZ. AsadiM. AzarbayjaniM.A. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation.Eur J Sport Sci2019197994100310.1080/17461391.2019.157111430732555
     [Google Scholar]
  33. SargeantJ.A. GrayL.J. BodicoatD.H. WillisS.A. StenselD.J. NimmoM.A. AithalG.P. KingJ.A. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: A systematic review and meta-analysis.Obes Rev201819101446145910.1111/obr.1271930092609
     [Google Scholar]
  34. CarraçaE.V. EncantadoJ. BattistaF. BeaulieuK. BlundellJ.E. BusettoL. van BaakM. DickerD. ErmolaoA. Farpour-LambertN. PramonoA. WoodwardE. BellichaA. OppertJ.M. Effect of exercise training on psychological outcomes in adults with overweight or obesity: A systematic review and meta-analysis.Obes Rev202122S4e1326110.1111/obr.1326133960106
     [Google Scholar]
  35. LaBrecqueD.R. AbbasZ. AnaniaF. FerenciP. KhanA.G. GohK.L. HamidS.S. IsakovV. LizarzabalM. PeñarandaM.M. RamosJ.F.R. SarinS. StimacD. ThomsonA.B.R. UmarM. KrabshuisJ. LeMairA. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.J Clin Gastroenterol201448646747310.1097/MCG.000000000000011624921212
     [Google Scholar]
  36. TsochatzisE.A. PapatheodoridisG.V. Is there any progress in the treatment of non-alcoholic fatty liver disease?World J Gastrointest Pharmacol Ther2011211510.4292/wjgpt.v2.i1.121577310
     [Google Scholar]
  37. YounossiZ.M. StepanovaM. TaubR.A. BarboneJ.M. HarrisonS.A. Hepatic fat reduction due to resmetirom in patients with nonalcoholic steatohepatitis is associated with improvement of quality of life.Clin Gastroenterol Hepatol202220613541361.e710.1016/j.cgh.2021.07.03934329774
     [Google Scholar]
  38. González-RuízK. Correa-BautistaJ.E. IzquierdoM. García-HermosoA. Martínez-VizcaínoV. LobeloF. González-JiménezE. Schmidt-RioValleJ. Correa-RodríguezM. Fernández-IrigoyenJ. Palomino-EcheverríaS. SantamaríaE. Ramírez-VélezR. Exercise dose on hepatic fat and cardiovascular health in adolescents with excess of adiposity.Pediatr Obes2022174e1286910.1111/ijpo.1286934734674
     [Google Scholar]
  39. KoperskaA. WesołekA. MoszakM. SzulińskaM. Berberine in non-alcoholic fatty liver disease: A review.Nutrients20221417345910.3390/nu1417345936079717
     [Google Scholar]
  40. Romero-GómezM. Zelber-SagiS. TrenellM. Treatment of NAFLD with diet, physical activity and exercise.J Hepatol201767482984610.1016/j.jhep.2017.05.01628545937
     [Google Scholar]
  41. KeatingS.E. HackettD.A. GeorgeJ. JohnsonN.A. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis.J Hepatol201257115716610.1016/j.jhep.2012.02.02322414768
     [Google Scholar]
  42. HallsworthK. AdamsL.A. Lifestyle modification in NAFLD/NASH: Facts and figures.JHEP Reports20191646847910.1016/j.jhepr.2019.10.00832039399
     [Google Scholar]
  43. EslamM. NewsomeP.N. SarinS.K. AnsteeQ.M. TargherG. Romero-GomezM. Zelber-SagiS. Wai-Sun WongV. DufourJ.F. SchattenbergJ.M. KawaguchiT. ArreseM. ValentiL. ShihaG. TiribelliC. Yki-JärvinenH. FanJ.G. GrønbækH. YilmazY. Cortez-PintoH. OliveiraC.P. BedossaP. AdamsL.A. ZhengM.H. FouadY. ChanW.K. Mendez-SanchezN. AhnS.H. CasteraL. BugianesiE. RatziuV. GeorgeJ. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.J Hepatol202073120220910.1016/j.jhep.2020.03.03932278004
     [Google Scholar]
  44. KeatingS.E. SabagA. HallsworthK. HickmanI.J. MacdonaldG.A. StineJ.G. GeorgeJ. JohnsonN.A. Exercise in the management of metabolic-associated fatty liver disease (MAFLD) in adults: A position statement from exercise and sport science Australia.Sports Med202353122347237110.1007/s40279‑023‑01918‑w37695493
     [Google Scholar]
  45. LiJ. HuangL. XiongW. QianY. SongM. Aerobic exercise improves non-alcoholic fatty liver disease by down-regulating the protein expression of the CNPY2-PERK pathway.Biochem Biophys Res Commun2022603354010.1016/j.bbrc.2022.03.00835278877
     [Google Scholar]
  46. GaoK.K. LiF-H. SuY-M. WangJ. YuX-M. RuanL. ZhangY-Z. Impact of exercise intervention-based remote monitoring for patients with different grades of non-alcoholic fatty liver disease severity.Sci Sports2024391627110.1016/j.scispo.2022.10.007
     [Google Scholar]
  47. EzpeletaM. GabelK. CienfuegosS. KalamF. LinS. PavlouV. SongZ. HausJ.M. KoppeS. AlexandriaS.J. Tussing-HumphreysL. VaradyK.A. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial.Cell Metab20233515670.e310.1016/j.cmet.2022.12.00136549296
     [Google Scholar]
  48. ZhuW. SaharN.E. JavaidH.M.A. PakE.S. LiangG. WangY. HaH. HuhJ.Y. Exercise-induced irisin decreases inflammation and improves NAFLD by competitive binding with MD2.Cells20211012330610.3390/cells1012330634943814
     [Google Scholar]
  49. D’AbbondanzaM. MinistriniS. PucciG. MigliolaE.N. MartorelliE.E. GandolfoV. SiepiD. PaganelliM.T. LupattelliG. VaudoG. Very low-carbohydrate ketogenic diet for the treatment of severe obesity and associated non-alcoholic fatty liver disease: The role of sex differences.Nutrition202187-8811132710.1016/j.nut.2021.111327
     [Google Scholar]
  50. ShidfarF. BahrololumiS.S. DoaeiS. MohammadzadehA. GholamalizadehM. MohammadimaneshA. The effects of extra virgin olive oil on alanine aminotransferase, aspartate aminotransferase, and ultrasonographic indices of hepatic steatosis in nonalcoholic fatty liver disease patients undergoing low calorie diet.Can J Gastroenterol Hepatol201820181710.1155/2018/105371029850450
     [Google Scholar]
  51. SpahisS. AlvarezF. AhmedN. DuboisJ. JalboutR. PaganelliM. GrzywaczK. DelvinE. PerettiN. LevyE. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: Impact of omega-3 fatty acids.J Nutr Biochem201858283610.1016/j.jnutbio.2018.03.02529864682
     [Google Scholar]
  52. NobiliV. AlisiA. MoscaA. CrudeleA. ZaffinaS. DenaroM. SmeriglioA. TrombettaD. The antioxidant effects of hydroxytyrosol and vitamin E on pediatric nonalcoholic fatty liver disease, in a clinical trial: A new treatment?Antioxid Redox Signal201931212713310.1089/ars.2018.770430588836
     [Google Scholar]
  53. ChenJ. VitettaL. Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications.Int J Mol Sci20202115521410.3390/ijms2115521432717871
     [Google Scholar]
  54. MeroniM. LongoM. DongiovanniP. The role of probiotics in nonalcoholic fatty liver disease: A new insight into therapeutic strategies.Nutrients20191111264210.3390/nu1111264231689910
     [Google Scholar]
  55. XiaoR. CaoY. WangL. TianP. ZhaiQ. ZhaoJ. WangG. ZhuY. The role of probiotics in the treatment of non-alcoholic fatty liver disease (NAFLD): New insights based on meta-analysis and subgroup analysis.Food Biosci20246210545410.1016/j.fbio.2024.105454
     [Google Scholar]
  56. KaufmannB. SeyfriedN. HartmannD. HartmannP. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.Am J Physiol Gastrointest Liver Physiol20233251G42G6110.1152/ajpgi.00017.202337129252
     [Google Scholar]
  57. CaoC. ShiM. WangX. YaoY. ZengR. Effects of probiotics on non-alcoholic fatty liver disease: A review of human clinical trials.Front Nutr202310115530610.3389/fnut.2023.115530637457967
     [Google Scholar]
  58. MaurottiS. PujiaR. FerroY. MareR. RussoR. CoppolaA. GazzarusoC. MontalciniT. PujiaA. PaoneS. MollaceV. MazzaE. A nutraceutical with Citrus bergamia and Cynara cardunculus improves endothelial function in adults with non-alcoholic fatty liver disease.Nutrition202411811229410.1016/j.nut.2023.11229438042043
     [Google Scholar]
  59. Mijangos-TrejoA. Nuño-LambarriN. Barbero-BecerraV. Uribe-EsquivelM. Vidal-CevallosP. Chávez-TapiaN. Prebiotics and probiotics: Therapeutic tools for nonalcoholic fatty liver disease.Int J Mol Sci202324191491810.3390/ijms24191491837834367
     [Google Scholar]
  60. RizzoM. CollettiA. PensonP.E. KatsikiN. MikhailidisD.P. TothP.P. Gouni-BertholdI. ManciniJ. MaraisD. MoriartyP. RuscicaM. SahebkarA. VinereanuD. CiceroA.F.G. BanachM. AcostaJ. Al-KhnifsawiM. AlnouriF. AmarF. AtanasovA.G. BajraktariG. BanachM. Gouni-BertholdI. BhaskarS. Bielecka-DąbrowaA. BjelakovicB. BruckertE. BytyçiI. CafferataA. CeskaR. CiceroA.F.G. ChlebusK. ColletX. DaccordM. DescampsO. DjuricD. DurstR. EzhovM.V. FrasZ. GaitaD. Gouni-BertholdI. HernandezA.V. JonesS.R. JozwiakJ. KakauridzeN. KallelA. KatsikiN. KheraA. KostnerK. KubiliusR. LatkovskisG. John ManciniG.B. David MaraisA. MartinS.S. MartinezJ.A. MazidiM. MikhailidisD.P. MirrakhimovE. MiserezA.R. MitchenkoO. MitkovskayaN.P. MoriartyP.M. Mohammad NabaviS. NairD. PanagiotakosD.B. ParaghG. PellaD. PensonP.E. PetrulionieneZ. PirroM. PostadzhiyanA. PuriR. RedaA. ReinerŽ. RadenkovicD. RakowskiM. RiadhJ. RichterD. RizzoM. RuscicaM. SahebkarA. SerbanM-C. ShehabA.M.A. ShekA.B. SirtoriC.R. StefanuttiC. TomasikT. TothP.P. ViigimaaM. ValdivielsoP. VinereanuD. VohnoutB. von HaehlingS. VrablikM. WongN.D. YehH-I. ZhishengJ. ZirlikA. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).Pharmacol Res202318910667910.1016/j.phrs.2023.10667936764041
     [Google Scholar]
  61. ZhaoM. ChenS. JiX. ShenX. YouJ. LiangX. YinH. ZhaoL. Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease.Pharmacol Res202116610551710.1016/j.phrs.2021.10551733636349
     [Google Scholar]
  62. ZhangC. FangT. ShiL. WangY. DengX. WangJ. ZhouY. The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiota.J Nutr Biochem202412510954610.1016/j.jnutbio.2023.10954638072206
     [Google Scholar]
  63. LeeN.K. LeeY. ShinD.S. ParkE. PaikH.D. Probiotic Lactiplantibacillus plantarum Lb41 alleviates high-fat diet-induced nonalcoholic fatty liver disease in mice.Nutrition202513411273510.1016/j.nut.2025.11273540147059
     [Google Scholar]
  64. CervelloM. AugelloG. CoccoL. RattiS. FolloM.Y. MartelliA.M. CusimanoA. MontaltoG. McCubreyJ.A. The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH.Adv Biol Regul20249210103210.1016/j.jbior.2024.10103238693042
     [Google Scholar]
  65. KotronenA. Peltonen M. Hakkarainen A. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.Gastroenterology2009137386510.1053/j.gastro.2009.06.005
     [Google Scholar]
  66. DelikA. DinçerS. AkkızH. The role of genetic and epigenetic factors in non alcoholic fatty liver disease (NAFLD) pathogenesis.Meta Gene20202410064710.1016/j.mgene.2020.100647
     [Google Scholar]
  67. OuyangW. Da WangM. Cheng GuanM. Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease.iLIVER20243210009810.1016/j.iliver.2024.100098
     [Google Scholar]
  68. LimaR.V.C. MaltaF. de M StefanoJ. T. O-12 MIR-181A as a biomarker of fibrosis in non-alcoholic fatty liver disease.Ann Hepatol20212410049910.1016/j.aohep.2021.100499
     [Google Scholar]
  69. BoyleM. TiniakosD. SchattenbergJ.M. RatziuV. BugianessiE. PettaS. OliveiraC.P. GovaereO. YounesR. McPhersonS. BedossaP. NielsenM.J. KarsdalM. LeemingD. KendrickS. AnsteeQ.M. Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease.JHEP Reports20191318819810.1016/j.jhepr.2019.06.00432039369
     [Google Scholar]
  70. YaoK. ChenZ. ZhouW. LiuZ. CuiW. Association between hemoglobin and non-alcoholic fatty liver disease (NAFLD) in United States adults: Results from NHANES 2017–2020.Prev Med Rep20244410279810.1016/j.pmedr.2024.10279838983448
     [Google Scholar]
  71. ZhangY. YeT. ZhouP. LiR. LiuZ. XieJ. HuaT. SunQ. Exercise ameliorates insulin resistance and improves ASK1-mediated insulin signalling in obese rats.J Cell Mol Med20212523109301093810.1111/jcmm.1699434734480
     [Google Scholar]
  72. BonsembianteL. TargherG. MaffeisC. Non-alcoholic fatty liver disease in obese children and adolescents: A role for nutrition?Eur J Clin Nutr2022761283910.1038/s41430‑021‑00928‑z34006994
     [Google Scholar]
  73. KimH.J. KwonO. Nutrition and exercise: Cornerstones of health with emphasis on obesity and type 2 diabetes management—A narrative review.Obes Rev2024258e1376210.1111/obr.1376238715378
     [Google Scholar]
  74. ViveroA. RuzM. RiveraM. MirandaK. SacristánC. EspinosaA. CodoceoJ. InostrozaJ. VásquezK. PérezÁ. García-DíazD. ArredondoM. Zinc supplementation and strength exercise in rats with type 2 diabetes: Akt and PTP1B phosphorylation in nonalcoholic fatty liver.Biol Trace Elem Res202119962215222410.1007/s12011‑020‑02324‑332939643
     [Google Scholar]
  75. CalcaterraV. MagenesV. VandoniM. BerardoC. MarinL. BianchiA. CordaroE. SilvestroG. SilvestriD. Carnevale PellinoV. CeredaC. ZuccottiG. Benefits of physical exercise as approach to prevention and reversion of non-alcoholic fatty liver disease in children and adolescents with obesity.Children202298117410.3390/children908117436010064
     [Google Scholar]
  76. ParryS.A. TurnerM.C. HodsonL. Lifestyle interventions affecting hepatic fatty acid metabolism.Curr Opin Clin Nutr Metab Care202023637337910.1097/MCO.000000000000068732833701
     [Google Scholar]
  77. HydesT.J. SummersN. BrownE. AlamU. Thomaides-BrearsH. WildingJ.P.H. CuthbertsonD.J. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes.Diabet Med202037111793180610.1111/dme.1435632619031
     [Google Scholar]
  78. SalavatizadehM. SoltaniehS. Ataei KachoueiA. Abdollahi FallahiZ. Kord-VarkanehH. PoustchiH. MansourA. KhamsehM.E. Alaei-ShahmiriF. SantosH.O. HekmatdoostA. Association between dietary glycemic index and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.Front Endocrinol (Lausanne)202314122807210.3389/fendo.2023.122807237674617
     [Google Scholar]
  79. BhattS.P. MisraA. NigamP. Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: A case control study.Diabetes Metab Syndr20191321271127410.1016/j.dsx.2019.01.05431336476
     [Google Scholar]
  80. YangK. Shao J. Wang Q. Would combination be better: Swimming exercise and intermittent fasting improve high-fat diet-induced nonalcoholic fatty liver disease in obese rats via the miR-122-5p/SREBP-1c/CPT1A pathway.Diabetes Metab Syndr Obes202417167510.2147/DMSO.S448165
     [Google Scholar]
  81. ChaiX.N. ZhouB.Q. NingN. PanT. XuF. HeS.H. ChenN.N. SunM. Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis.Front Endocrinol (Lausanne)202314108109610.3389/fendo.2023.108109636875459
     [Google Scholar]
  82. HinrichsH. FaerberA. YoungM. BallentineS.J. ThompsonM.D. Maternal exercise protects male offspring from maternal diet–programmed nonalcoholic fatty liver disease progression.Endocrinology20231643bqad01010.1210/endocr/bqad01036655378
     [Google Scholar]
  83. MunkongN. SomnukS. JantarachN. RuxsanawetK. NuntaboonP. KanjooV. YoysungnoenB. Red rice bran extract alleviates high-fat diet-induced non-alcoholic fatty liver disease and dyslipidemia in mice.Nutrients202315124610.3390/nu1501024636615905
     [Google Scholar]
  84. WillisS.A. MalaikahS. ParryS. BawdenS. EnnequinG. SargeantJ.A. YatesT. WebbD.R. DaviesM.J. StenselD.J. AithalG.P. KingJ.A. The effect of acute and chronic exercise on hepatic lipid composition.Scand J Med Sci Sports202333555056810.1111/sms.1431036610000
     [Google Scholar]
  85. ThomsenM.N. SkytteM.J. SamkaniA. CarlM.H. WeberP. AstrupA. ChabanovaE. FengerM. FrystykJ. HartmannB. HolstJ.J. LarsenT.M. MadsbadS. MagkosF. ThomsenH.S. HaugaardS.B. KrarupT. Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: A randomised controlled trial.Diabetologia202265350651710.1007/s00125‑021‑05628‑834993571
     [Google Scholar]
  86. PouwelsS. SakranN. GrahamY. LealA. PintarT. YangW. KassirR. SinghalR. MahawarK. RamnarainD. Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss.BMC Endocr Disord20222216310.1186/s12902‑022‑00980‑135287643
     [Google Scholar]
/content/journals/cnf/10.2174/0115734013384230250710024703
Loading
Influence of Physical Activity and Dietary Changes on Insulin Sensitivity in Non-alcoholic Fatty Liver Disease
Curr. Nutr. Food Sci. 21, 1040 (2025); https://doi.org/10.2174/0115734013384230250710024703
/content/journals/cnf/10.2174/0115734013384230250710024703
/content/journals/cnf/10.2174/0115734013384230250710024703
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): dietary changes; lifestyle interventions; liver health; Non-alcoholic fatty liver disease; obesity; physical activity

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test